Pharmaceutical Intermediates
- • Analgesics (59)
- • Anesthetics (52)
- • Anti-Addiction Agents (8)
- • Antibacterials (118)
- • Anticonvulsants (20)
- • Antidementia Agents (23)
- • Antidepressants (35)
- • Antiemetics (24)
- • Antifungals (24)
- • Antigout Agents (9)
- • Anti-inflammatory Agents (28)
- • Antimigraine Agents (21)
- • Antineoplastics (430)
- • Antiparasitics (11)
- • Antiparkinson Agents (28)
- • Antipsychotics (54)
- • Antispasticity Agents (12)
- • Antivirals (146)
- • Anxiolytics (16)
- • Blood Glucose Regulators (106)
- • Blood Products (61)
- • Cardiovascular Agents (179)
- • CNS Agents (22)
- • Dental and Oral Agents (8)
- • Dermatological Agents (19)
- • Electrolytes (15)
- • Gastrointestinal Agents (63)
- • Genetic/Enzyme Disorder (12)
- • Genitourinary Agents (47)
- • Immunological Agents (36)
- • Metabolic Bone Disease (6)
- • Ophthalmic Agents (476)
- • Respiratory Tract (51)
- • Skeletal Muscle Relaxants (5)
- • Sleep Disorder Agents (28)
- • Oled Material Intermediate (333)
- • Heterocyclic Compound (9770)
- • Bulk Drug Intermediates (17810)
Related News
Sleep Disorder Agents
6-Methoxy-1-indanone
(13623-25-1)-
Pharmaceutical Grade / 99%
-
Pharmaceutical Grade / 99%
-
pharmaceutical grade / 98%
-
Industrial Grade / pharmaceutical grade / 99%
Request for quotation , get quotes from more suppliers.
Source Sleep Disorder Agents Raw Materials by Region
More Information
Sleep Disorder Agents Intermediates are key raw materials used in the synthesis of pharmaceuticals targeting sleep disorders. These intermediates provide the foundation for sedatives, hypnotics, melatonin receptor modulators, and other sleep-regulating agents.
Common applications and types include:
• Sedative intermediates — for calming the central nervous system and promoting sleep onset.
• Hypnotic intermediates — used in treatments for insomnia and sleep maintenance.
• Melatonin receptor modulators — supporting therapies for circadian rhythm disorders.
• Adjunct intermediates — for drugs that enhance sleep quality and reduce sleep disturbances.
Frequently Asked Questions
Sleep Disorder Agents are pharmaceutical compounds used to treat various sleep-related conditions such as insomnia, sleep apnea, narcolepsy, and restless leg syndrome. These agents may include sedative-hypnotics, melatonin receptor agonists, orexin receptor antagonists, and other CNS-acting medications designed to regulate sleep-wake cycles and improve sleep quality.
Sleep Disorder Agents work through different pharmacological mechanisms depending on their class. For example, benzodiazepines enhance GABA activity to induce sedation, while melatonin agonists like ramelteon mimic the body’s natural sleep hormone. Newer agents such as suvorexant block orexin receptors to reduce wakefulness. Understanding these mechanisms helps clinicians select the most appropriate therapy based on the patient’s specific sleep disorder.
Common types of Sleep Disorder Agents include:1. Benzodiazepines (e.g., temazepam)2. Non-benzodiazepine hypnotics (e.g., zolpidem, eszopiclone)3. Melatonin receptor agonists (e.g., ramelteon)4. Orexin receptor antagonists (e.g., suvorexant, lemborexant)5. Antidepressants with sedative effects (e.g., trazodone, used off-label)Each class varies in onset, duration, side effect profile, and suitability for long-term use.
When sourcing Sleep Disorder Agents for pharmaceutical manufacturing, consider:1. Regulatory compliance (e.g., FDA, EMA, or local health authority approvals)2. API purity, stability, and documentation (including CoA and DMF)3. Supplier’s adherence to Good Manufacturing Practices (GMP)4. Scalability and consistency of supply5. Intellectual property status to avoid patent infringementSelecting a reliable supplier ensures product safety, efficacy, and regulatory compliance.
Yes, Sleep Disorder Agents can carry risks such as dependence, tolerance, next-day drowsiness, cognitive impairment, and complex sleep behaviors (e.g., sleepwalking). Benzodiazepines and Z-drugs may lead to withdrawal symptoms if discontinued abruptly. Newer agents like orexin antagonists generally have lower abuse potential but still require careful patient monitoring. Always follow clinical guidelines and prescribe the lowest effective dose for the shortest duration necessary.